Franklin Genomic Advancements ETF
Limited financial coverage for HELX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements.
- IPO
- 2020
- HQ
- San Mateo, CA, US
Get TickerSpark's AI analysis on HELX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $31.83M
- Div Yield
- 0.34%
- 52W High
- $42.88
- 52W Low
- $29.32
- 50D MA
- $39.28
- 200D MA
- $36.08
- Beta
- 0.98
- RSI (14)
- 65
- Avg Volume
- 2.52K
No earnings-call transcripts are available for HELX yet.
- Free Float
- 100.0%
- Shares Outstanding
- 750.06K
- Float Shares
- 750.06K
of shares held by institutions
6 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 3, 06 | TRANSIER WILLIAM L | other | 1,843 |
| Jul 3, 06 | DUROC-DANNER BERNARD J | other | 1,340 |
| May 25, 06 | FERRON MARTIN R | other | 5,655 |
| May 25, 06 | FERRON MARTIN R | other | 5,655 |
| Apr 5, 06 | TRIPODO ANTHONY | other | 15,000 |
| Apr 5, 06 | TRIPODO ANTHONY | other | 15,000 |
| Apr 5, 06 | TRIPODO ANTHONY | sell | 15,000 |
| May 18, 06 | PURSELL A WADE | other | 700 |
| May 15, 06 | KRATZ OWEN E | buy | 10,000 |
| May 4, 06 | KRATZ OWEN E | other | 15,832 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HELX coverage
Recent articles, reports, and earnings notes.
No research on HELX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HELX report →Best-Performing ETFs of Last Week: Healthcare Rules
zacks.com · Nov 24
Can Health Care Stocks Outperform Again In 2023?
seekingalpha.com · Jan 11
Why Now Could Be The Time To Consider Neuroscience Investments
seekingalpha.com · Aug 27
Hop on HELX for Potential Biotech M&A
etftrends.com · Jun 10
Invest in the Fully Mapped Human Genome With This ETF
etftrends.com · Apr 18
ETF Deathwatch For August 2020
seekingalpha.com · Sep 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.